Patent · US Active

Immunoglobulin variants and uses thereof

US8562992B2 · kind B2 · utility

65Cited by
40References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 2008
Grant dateOct 22, 2013
Priority date—
Expiry dateJul 27, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.